På ordinarie bolagsstämma i New Nordic Healthbrands AB (publ) den 28 april 2022 beslutades följande

New Nordic Healthbrands AB (publ) Three Month Report January - March 2022

Q1 2022

• Net sales amounted to MSEK 123,3 (127,8), a decrease of 8,6 percent in local currencies and 3,5 percent in SEK.
• Gross margin increased to 67,2 percent (67,0).
• EBITDA decreased to MSEK 2,0 (13,4).
• Operating profit decreased to MSEK 1,8 (13,2).
• Profit after tax for the period decreased to MSEK 1,0 (10,4).
• Earnings per share after tax decreased to SEK 0,16 (1,68).

New Nordic Healthbrands AB (publ) Annual Report 2021

Kallelse till årsstämma i New Nordic Healthbrands AB (publ)

Aktieägarna i New Nordic Healthbrands AB (publ) kallas härmed till årsstämma.

New Nordic Healthbrands AB (publ) Full Year Report January - December 2021

FULL YEAR 2021

• Net sales amounted to MSEK 514,8 (450,1), an increase of 17,3 percent in local currencies and 14,4 percent in SEK.
• Gross margin decreased to 68.0 percent (68,7).
• EBITDA increased to MSEK 29.5 (24.6).
• Operating profit increased to MSEK 28.5 (23.8).
• Profit after tax for the period increased to MSEK 21.3 (17.8).
• Earnings per share after tax increased to SEK 3.44 (2.87).

New Nordic Healthbrands AB (publ) has decided to postpone the application for listing on Nasdaq Main Market Stockholm

New Nordic Healthbrands AB (publ) has decided to postpone the application for listing on Nasdaq Main Market Stockholm. The application will be made late 2022 with the aim to list in 2023

New Nordic Healthbrands AB (publ) Nine Month Report January - September 2021

NINE MONTHS 2021

• Net sales amounted to MSEK 393.8 (332.3), an increase of 22.9 percent in local currencies and 18.5 percent in SEK.
• Gross margin decreased to 68.9 percent (69.3).
• EBITDA increased to MSEK 33.5 (20.0).
• Operating profit increased to MSEK 32.8 (19.4).
• Profit after tax for the period increased to MSEK 25.8 (15.1).
• Earnings per share after tax increased to SEK 4.16 (2.44).

New Nordic Healthbrands AB (publ) Six Month Report January - June 2021

FIRST HALF-YEAR 2021

• Net sales amounted to MSEK 268.9 (217,0), an increase of 30.8 percent in local currencies and 23,9 percent in SEK.
• Gross margin decreased to 68.0 percent (70.1).
• EBITDA increased to MSEK 24.6 (11.8).
• Operating profit increased to MSEK 24.1 (11.4).
• Profit after tax for the period increased to MSEK 19.1 (8.7).
• Earnings per share after tax increased to SEK 3.08 (1.40).

New Chief Operating Officer at New Nordic

På ordinarie bolagsstämma i New Nordic Healthbrands AB (publ) den 29 april 2021 beslutades följande